Clinical Investigations of Texas (CIT) is renowned for providing top-tier clinical research services to the pharmaceutical industry and Contract Research Organizations (CROs), while ensuring exceptional patient care.

CIT boasts a remarkable track record of more than 10 years of experience in conducting Phase II-IV clinical studies. During this time, they have collaborated with a wide range of pharmaceutical sponsors and CRO clients, solidifying their reputation as a dedicated and reliable research site.

CIT has expertise in various therapeutic areas, including but not limited to general medicine, cardiovascular conditions, rheumatology, diabetes, allergies, asthma, immunology, dermatology, and neurology. Moreover, they are in the process of expanding their focus to include pediatrics, vaccines, and infectious diseases.

Clinical Investigations of Texas maintains the highest quality standards in its clinical research services by leveraging its extensive experience in Phase II-IV studies. Their solid reputation and successful collaboration with diverse pharmaceutical sponsors and CRO clients attest to their commitment to excellence.